Mustapha Ezzeddine to Tissue Plasminogen Activator
This is a "connection" page, showing publications Mustapha Ezzeddine has written about Tissue Plasminogen Activator.
Connection Strength
0.976
-
Qureshi AI, Chaudhry SA, Sivagnanam K, Rodriguez GJ, Suri MF, Lakshminarayan K, Ezzeddine MA. Clinical-radiological severity mismatch phenomenon: patients with severe neurological deficits without matching infarction on computed tomographic scan. J Neuroimaging. 2013 Jan; 23(1):21-7.
Score: 0.426
-
Qureshi AI, Hussein HM, Janjua N, Harris-Lane P, Ezzeddine MA. Postprocedure intravenous eptifibatide following intra-arterial reteplase in patients with acute ischemic stroke. J Neuroimaging. 2008 Jan; 18(1):50-5.
Score: 0.303
-
Zacharatos H, Hassan AE, Vazquez G, Hussein HM, Rodriguez GJ, Suri MF, Lakshminarayan K, Ezzeddine MA, Qureshi AI. Comparison of acute nonthrombolytic and thrombolytic treatments in ischemic stroke patients 80 years or older. Am J Emerg Med. 2012 Jan; 30(1):158-64.
Score: 0.093
-
Qureshi AI, Ezzeddine MA, Nasar A, Suri MF, Kirmani JF, Janjua N, Divani AA. Is IV tissue plasminogen activator beneficial in patients with hyperdense artery sign? Neurology. 2006 Apr 25; 66(8):1171-4.
Score: 0.067
-
Chalela JA, Kang DW, Luby M, Ezzeddine M, Latour LL, Todd JW, Dunn B, Warach S. Early magnetic resonance imaging findings in patients receiving tissue plasminogen activator predict outcome: Insights into the pathophysiology of acute stroke in the thrombolysis era. Ann Neurol. 2004 Jan; 55(1):105-12.
Score: 0.057
-
Latour LL, Kang DW, Ezzeddine MA, Chalela JA, Warach S. Early blood-brain barrier disruption in human focal brain ischemia. Ann Neurol. 2004 Oct; 56(4):468-77.
Score: 0.015
-
Lattimore SU, Chalela J, Davis L, DeGraba T, Ezzeddine M, Haymore J, Nyquist P, Baird AE, Hallenbeck J, Warach S. Impact of establishing a primary stroke center at a community hospital on the use of thrombolytic therapy: the NINDS Suburban Hospital Stroke Center experience. Stroke. 2003 Jun; 34(6):e55-7.
Score: 0.014